{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:06:15Z","timestamp":1784073975253,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"DOI":"10.1007\/s11655-026-4161-5","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:55:13Z","timestamp":1784073313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Aconitine from Aconiti Lateralis Radix Praeparata (Fuzi) Suppresses Intrahepatic Cholangiocarcinoma via TOP2A: A Study Combining Machine Learning with Functional Validation"],"prefix":"10.1007","author":[{"given":"Shuang-nan","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-miao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"4161_CR1","doi-asserted-by":"publisher","first-page":"107064","DOI":"10.1016\/j.ejso.2023.107064","volume":"51","author":"M Qurashi","year":"2025","unstructured":"Qurashi M, Vithayathil M, Khan SA. Epidemiology of cholangiocarcinoma. Eur J Surg Oncol 2025;51:107064.","journal-title":"Eur J Surg Oncol"},{"key":"4161_CR2","first-page":"198","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, Allen PJ, Morse MA, Lidsky ME. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin 2023;73:198\u2013222.","journal-title":"CA Cancer J Clin"},{"key":"4161_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","volume":"79","author":"European Association for the Study of the Liver","year":"2023","unstructured":"European Association for the Study of the Liver. EASLILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 2023;79:181\u2013208.","journal-title":"J Hepatol"},{"key":"4161_CR4","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S2468-1253(19)30189-X","volume":"4","author":"MA Lowery","year":"2019","unstructured":"Lowery MA, Burris HA, Janku F, Shroff RT, Cleary JM, Azad NS, et al. Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study. Lancet Gastroenterol Hepatol 2019;4:711\u2013720.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4161_CR5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, Vaccaro G, Melisi D, Al-Rajabi R, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol 2020;21:671\u2013684.","journal-title":"Lancet Oncol"},{"key":"4161_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","volume":"73","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Barriuso J, McNamara MG, Valle JW. Molecular targeted therapies: ready for \u201cprime time\u201d in biliary tract cancer. J Hepatol 2020;73:170\u2013185.","journal-title":"J Hepatol"},{"key":"4161_CR7","first-page":"8005","volume":"56","author":"SN Yao","year":"2025","unstructured":"Yao SN, Sun WT, Chen ZY, Liu L, Wang YF. Pathogenesis and management strategies of hypercoagulable state in malignant tumors: integrating traditional Chinese and Western medicine. Chin Traditi Herb Drugs (Chin) 2025;56:8005\u20138014.","journal-title":"Chin Traditi Herb Drugs (Chin)"},{"key":"4161_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phymed.2018.03.001","volume":"44","author":"JJ Wu","year":"2018","unstructured":"Wu JJ, Guo ZZ, Zhu YF, Huang ZJ, Gong X, Li YH, et al. A systematic review of pharmacokinetic studies on herbal drug Fuzi: implications for Fuzi as personalized medicine. Phytomedicine 2018; 44:187\u2013203.","journal-title":"Phytomedicine"},{"key":"4161_CR9","doi-asserted-by":"publisher","first-page":"1151092","DOI":"10.3389\/fphar.2023.1151092","volume":"14","author":"Q Hu","year":"2023","unstructured":"Hu Q, Liu Y, Yu J, Yang X, Yang M, He Y, et al. The protective effect and antitumor activity of Aconiti Lateralis Radix Praeparata (Fuzi) polysaccharide on cyclophosphamide-induced immunosuppression in H22 tumor-bearing mice. Front Pharmacol 2023;14:1151092.","journal-title":"Front Pharmacol"},{"key":"4161_CR10","doi-asserted-by":"publisher","first-page":"155099","DOI":"10.1016\/j.phymed.2023.155099","volume":"126","author":"W Zhang","year":"2024","unstructured":"Zhang W, Ding M, Feng Y, Cai S, Luo Z, Shan J, et al. Modulation of cellular metabolism and alleviation of bacterial dysbiosis by Aconiti Lateralis Radix Praeparata in non-small cell lung cancer treatment. Phytomedicine 2024;126:155099.","journal-title":"Phytomedicine"},{"key":"4161_CR11","doi-asserted-by":"publisher","first-page":"115270","DOI":"10.1016\/j.jep.2022.115270","volume":"293","author":"Y Gao","year":"2022","unstructured":"Gao Y, Fan H, Nie A, Yang K, Xing H, Gao Z, et al. Aconitine: a review of its pharmacokinetics, pharmacology, toxicology and detoxification. J Ethnopharmacol 2022; 293:115270.","journal-title":"J Ethnopharmacol"},{"key":"4161_CR12","doi-asserted-by":"publisher","first-page":"1172939","DOI":"10.3389\/fphar.2023.1172939","volume":"14","author":"G Xiang","year":"2023","unstructured":"Xiang G, Xing N, Wang S, Zhang Y. Antitumor effects and potential mechanisms of aconitine based on preclinical studies: an updated systematic review and meta-analysis. Front Pharmacol 2023;14:1172939.","journal-title":"Front Pharmacol"},{"key":"4161_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.31083\/j.fbl2804075","volume":"28","author":"KH Ong","year":"2023","unstructured":"Ong KH, Lai HY, Sun DP, Chen TJ, Huang SK, Tian YF, et al. Prognostic significance of DNA topoisomerase II alpha (TOP2A) in cholangiocarcinoma. Front Biosci (Landmark Ed) 2023;28:75.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"4161_CR14","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.18632\/aging.102766","volume":"12","author":"L Guo","year":"2020","unstructured":"Guo L, Zhang Y, Yin Z, Ji Y, Yang G, Qian B, et al. Screening and identification of genes associated with cell proliferation in cholangiocarcinoma. Aging (Albany NY) 2020;12:2626\u20132646.","journal-title":"Aging (Albany NY)"},{"key":"4161_CR15","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res 2021;49:D1388\u2013D1395.","journal-title":"Nucleic Acids Res"},{"key":"4161_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res 2000;28:235\u2013242.","journal-title":"Nucleic Acids Res"},{"key":"4161_CR17","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455\u2013461.","journal-title":"J Comput Chem"},{"key":"4161_CR18","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des 2010;24:417\u2013422.","journal-title":"J Comput Aided Mol Des"},{"key":"4161_CR19","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/s42003-024-06801-6","volume":"7","author":"W Zhang","year":"2024","unstructured":"Zhang W, Cai S, Qin L, Feng Y, Ding M, Luo Z, et al. Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K\/AktmTOR signaling and glycolysis. Commun Biol 2024;7:1118.","journal-title":"Commun Biol"},{"key":"4161_CR20","doi-asserted-by":"crossref","unstructured":"Sun C, Jiang Y, Wang X. Fuzi-Baijiangcao herb pair alleviates DSS-induced ulcerative colitis in mice via inhibiting the p38 MAPK\/NF-\u03baB\/HIF-1\u03b1 signaling pathway. Comb Chem High Throughput Screen 2025 [Epub ahead of print].","DOI":"10.2174\/0113862073342236250103112654"},{"key":"4161_CR21","doi-asserted-by":"publisher","first-page":"1500527","DOI":"10.3389\/fphar.2024.1500527","volume":"15","author":"X Pan","year":"2025","unstructured":"Pan X, Liang T, Feng H, Liu W, Mou Q, Yan X. Toxicological landscape of Fuzi: a comprehensive study on the spatial distribution of toxicants and regional neurotoxicity variability in zebrafish. Front Pharmacol 2025;15:1500527.","journal-title":"Front Pharmacol"},{"key":"4161_CR22","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1016\/j.apsb.2020.01.014","volume":"10","author":"Z Li","year":"2020","unstructured":"Li Z, Lin Y, Song H, Qin X, Yu Z, Zhang Z, et al. First small-molecule PROTACs for G protein-coupled receptors: inducing \u03b1 (1A)-adrenergic receptor degradation. Acta Pharm Sini B 2020;10:1669\u20131679.","journal-title":"Acta Pharm Sini B"},{"key":"4161_CR23","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00210-005-0017-2","volume":"372","author":"WT Kassahun","year":"2005","unstructured":"Kassahun WT, G\u00fcnl B, Tannapfel A, Ungemach FR, Hauss J, Abraham G. Alpha1- and beta2-adrenoceptors in the human liver with mass-forming intrahepatic cholangiocarcinoma: density and coupling to adenylate cyclase and phospholipase C. Naunyn Schmiedebergs Arch Pharmacol 2005;372:171\u2013181.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4161_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jep.2019.02.011","volume":"235","author":"F Sun","year":"2019","unstructured":"Sun F, Huang Y, Li L, Wang Y, Zhuang P, Zhang Y. PKA\/\u03b22-AR-Gs\/Gi signaling pathway is associated with antiinflammatory and pro-apoptotic effects of Fuzi and Banxia combination on rats subjected to pressure overload. J Ethnopharmacol 2019;235:375\u2013384.","journal-title":"J Ethnopharmacol"},{"key":"4161_CR25","doi-asserted-by":"publisher","first-page":"eadd4920","DOI":"10.1126\/sciadv.add4920","volume":"8","author":"L Uusk\u00fcla-Reimand","year":"2022","unstructured":"Uusk\u00fcla-Reimand L, Wilson MD. Untangling the roles of TOP2A and TOP2B in transcription and cancer. Sci Adv 2022;8:eadd4920.","journal-title":"Sci Adv"},{"key":"4161_CR26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","volume":"31","author":"B Zhang","year":"2024","unstructured":"Zhang B, Li J, Wang Y, Liu X, Yang X, Liao Z, et al. Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis. Cell Death Differ 2024;31:309\u2013321.","journal-title":"Cell Death Differ"},{"key":"4161_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbadis.2017.10.019","volume":"1864","author":"YF Pei","year":"2018","unstructured":"Pei YF, Yin XM, Liu XQ. TOP2A induces malignant character of pancreatic cancer through activating \u03b2-catenin signaling pathway. Biochim Biophys Acta Mol Basis Dis 2018;1864:197\u2013207.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4161_CR28","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrc.2021.06.069","volume":"570","author":"F Zhang","year":"2021","unstructured":"Zhang F, Wu H. MiR-599 targeting TOP2A inhibits the malignancy of bladder cancer cells. Biochem Biophys Res Commun 2021;570:154\u2013161.","journal-title":"Biochem Biophys Res Commun"},{"key":"4161_CR29","doi-asserted-by":"publisher","first-page":"2325126","DOI":"10.1080\/15384047.2024.2325126","volume":"25","author":"K Zhang","year":"2024","unstructured":"Zhang K, Zheng X, Sun Y, Feng X, Wu X, Liu W, et al. TOP2A modulates signaling via the AKT\/mTOR pathway to promote ovarian cancer cell proliferation. Cancer Biol Ther 2024;25:2325126.","journal-title":"Cancer Biol Ther"},{"key":"4161_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.7150\/thno.63417","volume":"12","author":"XY Wang","year":"2022","unstructured":"Wang XY, Zhu WW, Wang Z, Huang JB, Wang SH, Bai FM, et al. Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities. Theranostics 2022;12:260\u2013276.","journal-title":"Theranostics"},{"key":"4161_CR31","doi-asserted-by":"publisher","first-page":"116472","DOI":"10.1016\/j.jpba.2024.116472","volume":"252","author":"W Zhang","year":"2025","unstructured":"Zhang W, Cai S, Luan W, Ding M, Di L. Integrated serum pharmacochemistry, network pharmacology and experimental verification to explore the mechanism of Aconiti Lateralis Radix Praeparata in treatment of lung cancer. J Pharm Biomed Anal 2025;252:116472.","journal-title":"J Pharm Biomed Anal"},{"key":"4161_CR32","doi-asserted-by":"publisher","first-page":"154071","DOI":"10.1016\/j.phymed.2022.154071","volume":"100","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhou L, Ge Y, Chen J, Du W, Xiao L, et al. Fuzi decoction ameliorates pain and cartilage degeneration of osteoarthritic rats through PI3K-Akt signaling pathway and its clinical retrospective evidence. Phytomedicine 2022;100:154071.","journal-title":"Phytomedicine"},{"key":"4161_CR33","first-page":"4955","volume":"20","author":"BL Ji","year":"2016","unstructured":"Ji BL, Xia LP, Zhou FX, Mao GZ, Xu LX. Aconitine induces cell apoptosis in human pancreatic cancer via NF-\u03baB signaling pathway. Eur Rev Med Pharmacol Sci 2016;20:4955\u20134964.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4161_CR34","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.3892\/mmr.2020.11322","volume":"22","author":"X Wang","year":"2020","unstructured":"Wang X, Lin Y, Zheng Y. Antitumor effects of aconitine in A2780 cells via estrogen receptor \u03b2-mediated apoptosis, DNA damage and migration. Mol Med Rep 2020;22:2318\u20132328.","journal-title":"Mol Med Rep"},{"key":"4161_CR35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1093\/jpp\/rgaa060","volume":"73","author":"Z Yang","year":"2021","unstructured":"Yang Z, Lin Y, Su C, Wang S, Gao L, Lin J, et al. Pharmacokinetics-based chronoefficacy of Fuzi against chronic kidney disease. J Pharm Pharmacol 2021;73:535\u2013544.","journal-title":"J Pharm Pharmacol"},{"key":"4161_CR36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/fcp.12761","volume":"36","author":"LY Li","year":"2022","unstructured":"Li LY, Zhang LM, Liao TT, Zhang CT, Chen KL, Huang Q. Advances on pharmacology and toxicology of aconitine. Fundam Clin Pharmacol 2022;36:601\u2013611.","journal-title":"Fundam Clin Pharmacol"},{"key":"4161_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13020-025-01291-y","volume":"21","author":"X Wang","year":"2026","unstructured":"Wang X, Shi X, Xi Z, Zhang Z, Luo Z, Wang J, et al. The scientific basis of synergy in traditional Chinese medicine: physicochemical, pharmacokinetic, and pharmacodynamic perspectives. Chin Med 2026;21:15.","journal-title":"Chin Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4161-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-026-4161-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-026-4161-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:55:14Z","timestamp":1784073314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-026-4161-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":37,"alternative-id":["4161"],"URL":"https:\/\/doi.org\/10.1007\/s11655-026-4161-5","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"9 February 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We declare no conflicts of interest for this submission and manuscript. No author received funding\/support from organizations with vested interests in study results, nor have personal\/professional relationships that might influence research objectivity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}